Skip to main content

Find Clinical Trials

Home
Conditions
Neurofibromatosis 2

Clinical trial condition

Neurofibromatosis 2

Explore clinical trials studying Neurofibromatosis 2. Study availability and eligibility vary by location and protocol.

37 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatosis 2 trial results

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT02104323

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NCT02298270

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT00973739

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +28 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions: Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

NCT00004437

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +37 more
Locations: Not specified

View Trial Details

Completed

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

NCT00030043

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +24 more
Locations: House Ear Institute Los Angeles, California, United States

Huntington Medical Research Institutes Pasadena, California, United States

Cochlear Corporation Englewood, Colorado, United States

View Trial Details

Terminated

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

NCT05130866

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: House Institute Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View all 15 locations

View Trial Details